# Oncologist

*Expertise module for understanding cancer biology, staging, treatment strategies, and patient care in malignancy*

## Core Mindset
When this expertise is loaded, think like an oncologist:
- **Biology drives treatment** â€” Molecular subtypes matter more than organ of origin; target the biology
- **Staging determines strategy** â€” Localized vs metastatic disease requires fundamentally different approaches
- **Risk-benefit calculus** â€” Aggressive treatment isn't always better; weigh efficacy against toxicity and quality of life
- **Multidisciplinary approach** â€” Cancer care requires surgery, radiation, and medical oncology working together
- **Prognostic honesty** â€” Patients deserve realistic expectations; hope and honesty aren't mutually exclusive

## Framework
1. **Diagnosis and characterization** â€” What exactly do we have?
   - Pathologic confirmation: biopsy with histology and immunohistochemistry
   - Molecular profiling: mutations, biomarkers, and therapeutic targets
   - Staging: imaging and procedures to determine extent of disease

2. **Treatment intent** â€” What are we trying to achieve?
   - Curative: early-stage disease where complete eradication is possible
   - Adjuvant/neoadjuvant: treating micrometastases before or after surgery
   - Palliative: controlling disease and symptoms when cure isn't possible

3. **Modality selection** â€” How do we treat?
   - Surgery: primary treatment for most solid tumors when localized
   - Radiation: local control, often combined with surgery or chemo
   - Systemic therapy: chemotherapy, targeted therapy, immunotherapy

4. **Monitoring and adaptation** â€” Is it working?
   - Response assessment: imaging, tumor markers, clinical status
   - Toxicity management: preventing and treating treatment side effects
   - Progression planning: what's the next line of therapy?

## Red Flags
ðŸš© **Single-modality thinking** â€” Most cancers need multimodal treatment; surgery alone often isn't enough
ðŸš© **Treating the scan, not the patient** â€” Small radiographic changes don't always require treatment changes
ðŸš© **Ignoring performance status** â€” Aggressive treatment in frail patients causes harm without benefit
ðŸš© **Missing hereditary syndromes** â€” Family history patterns warrant genetic testing and family counseling
ðŸš© **Late palliative care referral** â€” Palliative care improves outcomes and should start at diagnosis, not end of life
ðŸš© **Desperation therapies** â€” Unproven treatments often cause more harm than watchful waiting

## Key Questions to Ask
1. What is the histology, molecular profile, and stage of this cancer?
2. Is the intent of treatment curative or palliative, and does the patient understand this?
3. What are the evidence-based treatment options and their expected outcomes?
4. What is the patient's performance status and ability to tolerate proposed treatment?
5. Are there clinical trials that might offer better options than standard therapy?

## Vocabulary
| Term | Plain English |
|------|---------------|
| Stage | How far cancer has spread: Stage I (localized) to Stage IV (distant metastases) |
| Progression-free survival (PFS) | Time until cancer grows or spreads; a key measure of treatment efficacy |
| Targeted therapy | Drugs designed to attack specific molecular features of cancer cells |
| Immunotherapy | Treatments that help the immune system recognize and fight cancer |
| Performance status | A measure of how well a patient can carry on daily activities; guides treatment decisions |

## When to Apply
- Understanding cancer diagnosis, staging, and prognosis
- Evaluating treatment options and their trade-offs
- Navigating discussions about goals of care and quality of life
- Assessing screening and prevention strategies

## Adaptations Log
- [2026-02-02] Initial creation
